La vendita allo scoperto per Arcadia Biosciences dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Arcadia Biosciences. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Arcadia Biosciences (NASDAQ:RKDA) Azioni, Report sulle vendite allo scoperto

Arcadia Biosciences

Arcadia Biosciences Inc is a producer and marketer of plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water and others.

Arcadia Biosciences Inc

TD Cowen analyst Bill Katz maintains Apollo Global Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>) with a Buy and raises the price target from $165 to $178.

News

Price Target

Analyst Ratings

TD Cowen Maintains Buy on Apollo Global Management, Raises Price Target to $178

Adobe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) has outperformed the market over the past 10 years by 10.33% on an annualized basis producing an average annual return of 21.51%. Currently, Adobe has a market capitalization of $221.46 billion. 
Buying $1000 In ADBE: If an investor had bought $1000 of ADBE stock 10 years ago, it would be worth $7,016.66 today based on a price of $503.09 for ADBE at the time of writing.
<h3>Adobe's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730914362_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

ADBE

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $7,000 Today

Digital Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLR#NYSE">DLR</a>) has outperformed the market over the past 20 years by 5.74% on an annualized basis producing an average annual return of 14.08%. Currently, Digital Realty Trust has a market capitalization of $57.56 billion. 
Buying $1000 In DLR: If an investor had bought $1000 of DLR stock 20 years ago, it would be worth $14,055.33 today based on a price of $173.72 for DLR at the time of writing.
<h3>Digital Realty Trust's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730914357_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 20 Years Ago, You Would Have $14,000 Today

Shares of SolarEdge Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>) dropped 20% to $15.06 during Wednesday&#8217;s session. Several solar stocks are trading lower following Donald Trump&#8217;s <a href="https://www.benzinga.com/news/large-cap/24/11/41774549/trumps-big-tech-policies-what-gop-victory-means-for-apple-google-microsoft">presidential election victory</a>.
The Republican Party's gains across the House and Senate signal a potential shift away from the green energy policies that have bolstered SolarEdge's business model. 
Trump's campaign commitments included reducing federal support for renewables and easing regulations on fossil fuel industries, which poses a threat to SolarEdge's growth trajectory and the broader renewable energy sector.
What To Know: Trump's proposed energy agenda includes plans to phase out green energy tax incentives, such as the Federal Investment Tax Credit (FITC), which currently provides a 30% tax credit for solar installations.
Concerns could mount among investors that if Trump repeals or scales back this incentive, it could impact demand for solar installations in the U.S., especially in states that lack their own substantial renewable energy subsidies.
SolarEdge, a leading provider of solar inverters and energy management solutions, relies heavily on the continued expansion of solar power adoption. 
With the possible withdrawal of federal tax benefits, SolarEdge could face serious headwinds, as potential customers may be deterred by higher upfront costs in the absence of tax relief, which could stall the company's momentum in a key market.
Read Also: <a href="https://www.benzinga.com/news/large-cap/24/11/41774549/trumps-big-tech-policies-what-gop-victory-means-for-apple-google-microsoft">Trump&#8217;s Big Tech Policies: What GOP Victory Means For Apple, Google, Microsoft</a>
Impact of Potential Tariffs and Trade Policies: Additionally, Trump's stance on tariffs poses a potential risk to SolarEdge's supply chain. Trump has floated the idea of a universal 10% tariff on all imports, and a <a href="https://www.benzinga.com/news/24/11/41737933/trump-tariff-proposed-may-cost-americans-78b-in-spending-study">possible 60% tariff</a> on Chinese goods could have direct repercussions.
SolarEdge sources some of its key components from international suppliers, particularly in Asia. If such tariffs were enacted, the costs of inverters and other equipment could rise sharply, squeezing the company's margins or forcing it to pass on these costs to consumers, further challenging its competitive positioning in the U.S. market.
What Else: Trump&#8217;s previous administration took a deregulatory approach toward environmental policy, rolling back numerous climate and emissions regulations. Given Trump's preference for traditional energy sectors, SolarEdge could see a policy landscape less supportive of renewable energy initiatives and one more favorable to fossil fuels. 
Without strong Federal backing, the solar industry may struggle to maintain its current growth, potentially impacting SolarEdge's revenue from its U.S. operations, which constitute a significant portion of its business.
Read Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41778433/s-p-500-dow-hit-record-highs-after-trump-win-fear-index-drops-20">S&amp;P 500, Dow Hit Record Highs After Trump Win; Fear Index Drops 20%</a>
<h2 class="wp-block-heading">Should I Sell My SEDG Stock?</h2>
When deciding to hold on to or sell a stock, investors should consider their time horizon, unrealized gains and total return.
Shares of SolarEdge Technologies have decreased by 78.4% in the past year. An investor who bought shares of SolarEdge Technologies at the beginning of the year would take a loss of $76.39 per share if they sold it today. The stock has fallen 17.51% over the past month, meaning an investor who bought shares on Oct. 1 would see a capital loss of $6.33.
For access to advanced charting and analysis tools and stock data, check out <a href="https://pro.benzinga.com/">Benzinga PRO. Try it for free.</a>
SEDG has a 52-week high of $103.15 and a 52-week low of $14.82.

SEDG

Why SolarEdge Technologies (SEDG) Stock Is Down 20%

TD Cowen analyst Bill Kirk maintains TPG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPG#NASDAQ">TPG</a>) with a Hold and lowers the price target from $62 to $58.

TD Cowen Maintains Hold on TPG, Lowers Price Target to $58

Goldman Sachs analyst Bruno Montanari maintains Xometry (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XMTR#NASDAQ">XMTR</a>) with a Buy and raises the price target from $24 to $28.

XMTR

Goldman Sachs Maintains Buy on Xometry, Raises Price Target to $28

Live On CNBC: Steve Weiss Buys CRH Public Limited Company

Sysco's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYY#NYSE">SYY</a>) short percent of float has fallen 15.52% since its last report. The company recently reported that it has 13.89 million shares sold short, which is 2.83% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.6 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Sysco Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730914223_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Sysco has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Sysco's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Sysco's peer group average for short interest as a percentage of float is 4.32%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Sysco?

Fabrinet's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) short percent of float has risen 6.82% since its last report. The company recently reported that it has 1.47 million shares sold short, which is 5.64% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.32 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Fabrinet Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730914218_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Fabrinet has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Fabrinet's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Fabrinet's peer group average for short interest as a percentage of float is 2.91%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(FN) - Analyzing Fabrinet's Short Interest

AvalonBay Communities's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVB#NYSE">AVB</a>) short percent of float has fallen 12.16% since its last report. The company recently reported that it has 2.97 million shares sold short, which is 2.89% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.95 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>AvalonBay Communities Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1730914213_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for AvalonBay Communities has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing AvalonBay Communities's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, AvalonBay Communities's peer group average for short interest as a percentage of float is 3.89%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(AVB) - Analyzing AvalonBay Communities's Short Interest

ROIC

Trading Halt: Halt status updated at 12:30:00 PM ET: Quotation Resumption: News and Resumption Times

TD Cowen analyst Joseph Giordano maintains Sensata Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ST#NYSE">ST</a>) with a Buy and lowers the price target from $50 to $45.

TD Cowen Maintains Buy on Sensata Technologies, Lowers Price Target to $45

Goldman Sachs analyst Salveen Richter maintains uniQure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QURE#NASDAQ">QURE</a>) with a Neutral and lowers the price target from $10 to $9.

QURE

Goldman Sachs Maintains Neutral on uniQure, Lowers Price Target to $9

WIIM

AMBA

INTC

LSCC

MRVL

NVDA

NXPI

QCOM

SLAB

Shares of companies in the broader semiconductor and chip sector are trading higher amid overall market strength following the US presidential election.

SMRT

SmartRent shares are trading lower after the company reported worse-than-expected Q3 financial results.

Montrose Environmental Group shares are trading lower after B of A Securities downgraded the stock from Buy to Neutral and cut its price target from $52 to $29.

Ero Copper shares are trading lower after the company reported worse-than-expected Q3 financial results. Also, the company's co-founder and chairman retired.

TD Cowen analyst Jason Seidl maintains GXO Logistics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GXO#NYSE">GXO</a>) with a Buy and raises the price target from $82 to $83.

TD Cowen Maintains Buy on GXO Logistics, Raises Price Target to $83

Goldman Sachs analyst George Tong maintains UL Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ULS#NYSE">ULS</a>) with a Neutral and raises the price target from $45 to $51.

Goldman Sachs Maintains Neutral on UL Solutions, Raises Price Target to $51

TD Cowen analyst Joseph Giordano maintains Xylem (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYL#NYSE">XYL</a>) with a Hold and lowers the price target from $138 to $125.

TD Cowen Maintains Hold on Xylem, Lowers Price Target to $125

An update from Arcadia Biosciences (RKDA) is now available. Arcadia Biosciences, Inc. has elevated Thomas J. Schaefer to a Class I director positio...

Arcadia Biosciences Appoints Thomas Schaefer as Class I Director

Arcadia Biosciences Q2 Earnings Preview

Here's the major earnings after the close today

Arcadia Biosciences GAAP EPS of $0.78 misses by $0.77, revenue of $1.31M beats by $0.38M

Arcadia Biosciences, Inc. (RKDA) Q2 2024 Earnings Call Transcript

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Arcadia Biosciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/rkda-stock-quote/">RKDA</a>) just reported results for the second quarter of 2024.<ul><li>Arcadia Biosciences reported earnings per share of 78 cents. This was below the analyst estimate for EPS of $1.55.</li><li>The company reported revenue of $1.31 million.</li><li>This was 41.96% better than the analyst estimate for revenue of $920,000.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/rkda-stock-earnings-arcadia-biosciences-for-q2-of-2024/">RKDA Stock Earnings: Arcadia Biosciences Misses EPS, Beats Revenue for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

RKDA Stock Earnings: Arcadia Biosciences Misses EPS, Beats Revenue for Q2 2024

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are a hot topic on Wednesday and we have all of the biggest stories traders need to know about this morning!



Moving stocks this morning are earnings reports, a stock offering, a reverse stock split and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Digital Ally (NASDAQ:<a href="https://investorplace.com/stock-quotes/dgly-stock-quote/">DGLY</a>) stock is rocketing more than 107% alongside heavy pre-market trading.</li>



<li>Viracta Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/virx-stock-quote/">VIRX</a>) shares are soaring over 53% with the <a href="https://www.nasdaq.com/press-release/viracta-therapeutics-reports-second-quarter-2024-financial-results-and-provides">release of its Q2 earnings report</a>.</li>



<li>Conduit Pharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/cdt-stock-quote/">CDT</a>) stock is surging more than 42% on <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318518494&amp;type=PDF&amp;symbol=CDT&amp;cdn=197541151657f71d6ed19abcc1e0e48e&amp;companyName=Conduit+Pharmaceuticals+Inc.&amp;formType=3&amp;formDescription=Initial+statement+of+beneficial+ownership+of+securities&amp;dateFiled=2024-08-13">an investment update</a>.</li>



<li>Nuburu (NYSEMKT:<a href="https://investorplace.com/stock-quotes/buru-stock-quote/">BURU</a>) shares are rising over 26% despite a lack of news this morning.</li>



<li>Jianzhi Education Technology (NASDAQ:<a href="https://investorplace.com/stock-quotes/jz-stock-quote/">JZ</a>) stock is gaining close to 19% even with a <a href="https://www.nasdaq.com/press-release/jianzhi-education-technology-group-company-limited-receives-nasdaq-notification-0">recent delisting notice</a>.</li>



<li>Edible Garden (NASDAQ:<a href="https://investorplace.com/stock-quotes/edbl-stock-quote/">EDBL</a>) shares are increasing more than 18% on <a href="https://www.nasdaq.com/press-release/edible-garden-reports-157-increase-gross-profit-fueled-year-over-year-growth-61-cut">strong Q2 earnings</a>.</li>



<li>Ucloudlink (NASDAQ:<a href="https://investorplace.com/stock-quotes/ucl-stock-quote/">UCL</a>) stock is heading over 16% higher with its <a href="https://www.nasdaq.com/press-release/ucloudlink-group-inc-announces-unaudited-second-quarter-2024-financial-results-2024">most recent earnings report</a>.</li>



<li>Vertex Energy (NASDAQ:<a href="https://investorplace.com/stock-quotes/vtnr-stock-quote/">VTNR</a>) shares are jumping 16% with strong early morning trading.</li>



<li>Serve Robotics (NASDAQ:<a href="https://investorplace.com/stock-quotes/serv-stock-quote/">SERV</a>) stock is climbing more than 15% with its <a href="https://www.stocktitan.net/news/SERV/serve-robotics-announces-second-quarter-2024-wqwtqr037uv4.html">Q2 earnings report</a>.</li>



<li>Kamada (NASDAQ:<a href="https://investorplace.com/stock-quotes/kmda-stock-quote/">KMDA</a>) shares are up over 15% after posting <a href="https://www.nasdaq.com/press-release/kamada-reports-strong-second-quarter-and-first-half-2024-financial-results-year-over">positive Q2 earnings results</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>TC BioPharm (NASDAQ:<a href="https://investorplace.com/stock-quotes/tcbp-stock-quote/">TCBP</a>) stock is crashing more than 42% after <a href="https://www.nasdaq.com/press-release/tc-biopharm-announces-pricing-20-registered-direct-offering-2024-08-13">pricing a registered direct offering</a>.</li>



<li>Surgepays (NASDAQ:<a href="https://investorplace.com/stock-quotes/surg-stock-quote/">SURG</a>) shares are plummeting over 26% after <a href="https://www.prnewswire.com/news-releases/surgepays-announces-second-quarter-2024-financial-results-302221503.html">reporting a Q2 loss</a>.</li>



<li>Arcadia Biosciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/rkda-stock-quote/">RKDA</a>) stock is diving more than 16% after <a href="https://markets.businessinsider.com/news/stocks/rkda-stock-earnings-arcadia-biosciences-for-q2-of-2024-1033684150">missing Q2 EPS estimates</a>.</li>



<li>Ouster (NYSE:<a href="https://investorplace.com/stock-quotes/oust-stock-quote/">OUST</a>) shares are taking an over 16% beating on <a href="https://www.businesswire.com/news/home/20240813944318/en/Ouster-Reports-Strong-Revenue-and-Margins-for-Second-Quarter-2024">mixed Q2 earnings</a>.</li>



<li>QuickLogic (NASDAQ:<a href="https://investorplace.com/stock-quotes/quik-stock-quote/">QUIK</a>) stock is tumbling more than 16% with its <a href="https://www.prnewswire.com/news-releases/quicklogic-reports-41-year-over-year-revenue-growth-for-second-quarter-fiscal-2024-302221555.html">latest earnings release</a>.</li>



<li>Brinker International (NYSE:<a href="https://investorplace.com/stock-quotes/eat-stock-quote/">EAT</a>) shares are sliding over 16% after <a href="https://www.investing.com/news/stock-market-news/brinker-international-stock-tumbles-13-on-q4-earnings-miss-93CH-3570960">posting an earnings miss</a>.</li>



<li>Portage Biotech (NASDAQ:<a href="https://investorplace.com/stock-quotes/prtg-stock-quote/">PRTG</a>) stock is falling more than 15% after <a href="https://www.stocktitan.net/news/PRTG/portage-biotech-announces-1-for-20-reverse-stock-sficaewojjpr.html">announcing a reverse stock split</a>.</li>



<li>Global E Online (NASDAQ:<a href="https://investorplace.com/stock-quotes/glbe-stock-quote/">GLBE</a>) shares are decreasing over 14% with its <a href="https://www.stocktitan.net/news/GLBE/global-e-reports-second-quarter-2024-1dq5hcfetvn1.html">Q2 earnings report</a>.</li>



<li>Bionomics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bnox-stock-quote/">BNOX</a>) stock is dropping more than 14% without any clear news this morning.</li>



<li>WISeKey (NASDAQ:<a href="https://investorplace.com/stock-quotes/wkey-stock-quote/">WKEY</a>) shares close out our pre-market stock movers down nearly 14% on a <a href="https://www.nasdaq.com/press-release/sealcoin-secures-50-million-investment-commitment-gem-digital-limited-through-0">new investment</a> <a href="https://www.nasdaq.com/press-release/wisekey-partners-venafi-post-quantum-encryption-services-2024-08-14">and partnership</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/2024/08/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-wednesday-aug-14th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

In a report released today, Ben Klieve from Lake Street maintained a Buy rating on Arcadia Biosciences (RKDA – Research Report), with a price targe...

Lake Street Sticks to Its Buy Rating for Arcadia Biosciences (RKDA)

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Summit Therapeutics (SMMT – Research Report) and Arc...

Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (SMMT) and Arcadia Biosciences (RKDA)

Warning: RKDA is at high risk of performing badly

ACHV

ARMN

ASXC

BEEM

BNOX

BURU

CTSO

CURI

DGLY

DPRO

DRRX

EDBL

FLUT

GLBE

GROY

HIVE

IMOS

KMDA

KNTNF

LAAC

LGMK

MRCY

NVVE

NWHUF

OUST

PRTG

QFIN

QUIK

REED

RKDA

SERV

SHWZ

SMMT

SURG

TCBP

VIRX

VTGN

VTNR

WKEY

WPRT

ZVRA

Press Releases

Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2023 Financial Results and Business Highlights

Arcadia Biosciences (RKDA) Announces Date of First Quarter 2024 Financial Results and Business Highlights Conference Call

Arcadia Biosciences (RKDA) Announces First Quarter 2024 Financial Results and Business Highlights

Arcadia Biosciences (RKDA) Announces Sale of Resistant Starch Durum Wheat Trait to Corteva Agriscience (CTVA)

Arcadia Biosciences (RKDA) Announces Sale of GoodWheatTM to Above Food Corp.

Arcadia Biosciences (RKDA) To Host Investor Call To Discuss Recent Transactions

Arcadia Biosciences (RKDA) Announces Leadership Transition

Arcadia Biosciences (RKDA) Announces Date of Second Quarter 2024 Financial Results and Business Highlights Conference Call

Arcadia Biosciences (RKDA) Announces Second-Quarter and First-Half 2024 Financial Results and Business Highlights

Arcadia Biosciences (RKDA) Announces Date of Third Quarter 2024 Financial Results and Business Highlights Conference Call

Archer-Daniels-Midland Company Common Stock

Archer-Daniels Midland

AgriFORCE Growing Systems Ltd. - Common Shares

AgriFORCE Growing Systems

Alico

Bunge Global

Benson Hill

Cresud S.A.C.I.F. y A. - American Depositary Shares, each representing ten shares of Common Stock

Comments

Arcadia Biosciences

Vendite allo scoperto

Arcadia Biosciences (NASDAQ:RKDA) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO